ANTIBODY, POLYCLONAL
Catalog no.: A 8102.1 / A 8102.2
Immunogen: Succinyl CAMP- human serum albumin conjugate
Synonyms: Cyclic adenosine monophosphate
Host: Rabbit
Matrix: Serum
Specificity: cAMP
Cross-reactivity at 50 % displacement:
AMP < 0.00001 %, ADP < 0.00002 %, ATP < 0.00001 %; cGMP < 0.001 %
Contents: 20 μl / 100 μl (lyophilized)
Resuspend in 20 μl / 100 μl aqua bidest.
Known applications: RIA1, 2, 3, 4, 5, 6
Antigen binding capacity: Dilutions 1/5000 bound 45-50 % of the labelled (radioactive) nucleotide.
This antibody has not been tested for use in all applications. This does not necessarily exclude its use for non-tested procedures. The stated dilutions are recommendations only. We suggest that the applicant titrates the antibody in his/her system using appropriate negative/positive controls.
Store at: 2-8 °C (lyophilized); - 20 °C (dissolved)
Repeated thawing and freezing must be avoided
References:
1. Zubin P, Taleisnik S (1983).Hypothalamic Cyclic-AMP Throughout the 4-Day Estrous Cycle of the Female Rat. Brain Research. 271: 273-277.
2. Zubin P, Taleisnik (1989). Hypothalamic cyclic AMP after the injection of ovarian steroids into ovariectomized rats. Can. J. Physlol. Pharmacol. 67: 322-325.
3. ZubinP, Defagot C, Taleisnik S (1992). Norepinephrine--stimulated activity of hypothalamic adenylate cyclase varies throughout the estrous cycle of the female rat. Acta Physiol Pharmacol Ther Latinoam 42(3): 171-181.
4. Zubin P, Defagot C (1993). Sexual dfferences in hypothalamic adenosine 3'5'-cyclic monophosphate content. Can J Physiol Pharmaco171(10-11): 824-828.
5. Defagot C, Zubin P (1994). Preparation, production and functional characterization of anti cAMP and cGMP antibodies. Biol. Res 27: 193-197.
6. Zubin P, Defagot C (1994). Effect of ovarian steroids on hypothalamic norepinephrine-induced adenylate cyclase activity. Can J Physiol Pharmacol 72(11): 1299-1303.